Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Thorough evaluation is crucial for understanding diffuse scalp hair loss.

Many patients with Giant Cell Arteritis did not follow their steroid treatment plans properly.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

A Nigerian teenager was diagnosed with neuropsychiatric lupus, showing various severe symptoms and abnormal lab results.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

Alopecia areata and polymyalgia rheumatica may be linked autoimmune conditions.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.